Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis

References

• American College of Ftheumatology subcommittee on rheumatoid arthritis guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 2002;46:328–46.
   PubMedGoogle Scholar
• Breedveld FC, Emery P, Keystone E, Patel K, Furst DE, Kalden JR, et al. Infliximab in active early rheumatoid arthritis. Ann Rheum Dis 2004;63:149–55.
   PubMed Web of Science ®Google Scholar
• Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheu-matoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000;343:1594–602.
   Google Scholar
• Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:2275–85.
   PubMed Web of Science ®Google Scholar
• Tenenbaum J, Urowitz MB, Keystone EC, Dwosh IL, Curtis JE. Leucapheresis in severe rheumatoid arthritis. Ann Rheum Dis 1979;38:40–4.
   PubMed Web of Science ®Google Scholar
• Wallace DJ, Goldfinger D, Gatti R, Lowe C, Fan P, Bluestone R, Klinenberg JR. Plasmapheresis and lymphoplasmapheresis in the management of rheumatoid arthritis. Arthritis Rheum 1979;22: 703–10.
   PubMed Web of Science ®Google Scholar
• Karsh J, Wright DG, Klippel JH, Decker JL, Deisseroth AB, Bye MW Lymphocyte depletion by continuous flow cell centrifugation in rheumatoid arthritis: clinical effects. Arthritis Rheum 1979;22: 1055–9.
   PubMed Web of Science ®Google Scholar
• Karsh J, Klippel JH, Plotz PH, Decker JL, Wright DG, Flye MW. Lymphapheresis in rheumatoid arthritis. A randomized trial. Arthritis Rheum. 1981;24:867–73.
   PubMed Web of Science ®Google Scholar
• Wallace D, Goldfinger D, Lowe C, Nichols S, Weiner J, Brachman M, et al. A double-blind, controlled study of lymphoplasmapheresis versus sham apheresis in rheumatoid arthritis. N Engl J Med 1982;306:1406–10.
   PubMed Web of Science ®Google Scholar
• Wahl SM, Wilder RL, Katona IM, Wahl LM, Allen JB, Scher I, et al. Leukapheresis in rheumatoid arthritis. Association of clinical improvement with reversal of anergy. Arthritis Rheum 1983; 26:1076–84.
   PubMed Web of Science ®Google Scholar
• Verdickt W, Dequeker J, Ceuppens JL, Stevens E, Gautama K, Vermylen C. Effect of lymphoplasmapheresis on clinical indices and T cell subsets in rheumatoid arthritis. A double-blind con-trolled study. Arthritis Rheum 1983;26:1419–26.
   Google Scholar
• Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Kataharada K, Ishizuka T, et al. Filtration leukocytapheresis therapy in rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1999;42:431–7.
   Google Scholar
• Ueki Y, Yamasaki S, Kanamoto Y, Kawazu T, Yano M, Matsumoto K, et al. Evaluation of filtration leucocytapheresis for use in the treatment of patient with rheumatoid arthritis. Ftheumatology 2000;39:165–71.
   PubMed Web of Science ®Google Scholar
• Kempe K, Tsuda H, Yang K, Yamaji K, Kanai Y, Hashimoto H. Filtration leukocytapheresis therapy in the treatment of rheuma-toid arthritis patients resistant to or failed with methotrexate. Ther Apher Dial 2004;8:197–205.
   PubMedGoogle Scholar
• Izumi Y, Tominaga M, Iwanaga N, Huang M, Tanaka F, Aratake K, et al. Twenty-four-week follow-up examination of a leukocyta-pheresis therapy in rheumatoid arthritis. Mod Ftheumatol 2006; 16:20–3.
   PubMedGoogle Scholar
• Ueki Y, Sagawa A, Tanimura K, Yamada A, Yamamoto K, Tsuda H, et al. A multicenter study of leukocytapheresis in rheumatoid arthritis. Clin Exp Ftheumatol; in press.
   Google Scholar
• Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a pro-spective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.
   Google Scholar
• DAS-Score.n1 [homepage on the Internet]. Netherlands: The department of rheumatology, University Medical Centre Nijme-gen. Available from: http://www.das-score.nY
   Google Scholar
• Nishimura T, Oka S, Yamawaki N. Technical aspects of leucocyte depletion. In: Hogman CF, editor. Leucocyte depletion of blood components. Amsterdam: VU University Press; 1994. p. 51–8.
   Google Scholar
• Ueki Y, Nakamura H, Kanamoto Y, Miyazaki M, Yano M, Matsu-moto K, et al. Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheu-matoid arthritis. Ther Apher 2001;5:455–61.
   Google Scholar
• Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Okada M, Ishizuka T, et al. Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocy-tapheresis therapy in patients with rheumatoid arthritis. Ther Apher 1999;3: 178–85.
   Google Scholar
• Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res. 2000;2: 189–202.
   Google Scholar
• Hahn G, Stuhlmuller B, Hain N, Kalden JR, Pfizenmaier K, Bur-mester GR. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy. J Chin Invest 1993; 91:862–70.
   Google Scholar
• Wang F, Wang NS, Yan CG, Li JH, Tang LQ. The significance of platelet activation in rheumatoid arthritis. Clin Rheumatol 2007;26: 768–71.
   Google Scholar
• Fukunaga K, Fukuda Y, Yokoyama Y, Ohnishi K, Kusaka T, Kosaka T, et al. Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients. J Gastroenterol 2006;41:524–32.
   PubMedGoogle Scholar
• Yagi Y, Andoh A, Inatomi 0, Bamba S, Tsujikawa T, Fujiyama Y, et al. Modulation of platelet aggregation responses by leukocy-tapheresis therapy in patients with active ulcerative colitis. J Gas-troenterol 2006;41:540–6.
   Google Scholar
• Onuma S, Yamaji K, Kempe K, Ogasawara M, Ogawa T, Yang K, et al. Investigation of the clinical effect of large volume leukocy-tapheresis on methotrexate-resistant rheumatoid arthritis. Ther Apher Dial 2006;10:404–11.
   PubMed Web of Science ®Google Scholar